Satellite Banner
Technology Networks Header
Thursday, December 18, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
QIAGEN to Distribute altona Diagnostic’s RealStar® Ebolavirus RT-PCR Kit 1.0
Tuesday, December 09, 2014
New molecular diagnostic test detects but does not differentiate all existing strains of Ebola virus.

Limited Time Sale from Bibby Scientific
Thursday, December 04, 2014
Web Shop offers savings of up to 15% on all laboratory equipment.

IDT and Ubiquitome Partner to Develop Mobile Ebola Test
Wednesday, December 03, 2014
Handheld, battery-powered Freedom4 enables rapid field deployment of gold standard molecular test.

Verifying the Quality and Quantity of your ChIP DNA
Tuesday, November 25, 2014
Porvair Sciences has published a new guide to help laboratories choose the best way to verify the quality and quantity of their Chromatin Immunoprecipitation (ChIP) DNA.

IDT Launches GMP MGB Eclipse® Probes for In Vitro Diagnostic Use
Tuesday, November 11, 2014
High quality, excellent service, and product transparency for human qPCR diagnostic applications.

Bio-Rad Introduces System to Automate Operation of Real-Time PCR Instruments
Monday, November 03, 2014
The CFX Automation System II automates the operation of up to two CFX Real-Time PCR Detection Systems.

Bio-Rad’s New Automated Droplet Generator
Tuesday, October 28, 2014
New AutoDG™ instrument for Droplet Digital™ PCR saves time and improves data quality.

Bio-Rad Adds New PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, October 22, 2014
This release expands Bio-Rad’s current offering of predesigned and fully wet-lab validated assays.

Bio-Rad Introduces Real-Time PCR Assays for Rat Genome
Thursday, October 09, 2014
Wet-lab validated PrimePCR™ Rat Genome Assays ensure accurate quantitative PCR results.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 594
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn